Colin Tang

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 1.8K citations

Urology, Surgical Oncology, High-risk Prostate Cancer +12

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Charles Catton, Himu Lukka, Chu‐Shu Gu et al. · Journal of Clinical Oncology · 2017 · 683 citations

Radiation Medicine, Nuclear Medicine, Urology +13

The Impact of ⁶⁸Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study

Paul Roach, Roslyn J. Francis, Louise Emmett et al. · Journal of Nuclear Medicine · 2017 · 355 citations · Full text

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne et al. · The Lancet Oncology · 2020 · 349 citations · Full text

Surgical Oncology, Urology, Radiation Therapy +10

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: Toxicity, biochemical, and pathological outcomes

Andrew Loblaw, Patrick Cheung, Laura D’Alimonte et al. · Radiotherapy and Oncology · 2013 · 164 citations

Urology, Radiation Medicine, Radiation Therapy +8